首页> 外文OA文献 >Corrigendum to “Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis” J Cyst Fibros, 10(2011)350-356

【2h】

Corrigendum to “Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis” J Cyst Fibros, 10(2011)350-356

机译：“PANCREAZE®治疗因囊性纤维化引起的外分泌性胰腺功能不全的疗效和安全性”更正J Cyst Fibros，10（2011）350-356

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Trapnell Bruce C.; Strausbaugh Steven D.; Woo Marlyn S.; Tong Shin-Yir; Silber Steven A.; Mulberg Andrew E.; Leitz Gerhard;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Corrigendum to "Efficacy and safety of PANCREAZE? for treatment of exocrine pancreatic insufficiency due to cystic fibrosis" [J Cyst Fibros, 10(2011)350-356] [J] . TrapnellB.C., StrausbaughS.D., WooM.S., Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society . 2011,第6期

机译：“PANCREAZE®治疗因囊性纤维化引起的外分泌性胰腺功能不全的疗效和安全性”更正[J Cyst Fibros，10（2011）350-356]
2. Efficacy and safety of PANCREAZE(R) for treatment of exocrine pancreatic insufficiency due to cystic fibrosis. [J] . Trapnell BC, Strausbaugh SD, Woo MS, Journal of cystic fibrosis: official journal of the European Cystic Fibrosis Society . 2011,第5期

机译：PANCREAZE（R）治疗由于囊性纤维化而导致的外分泌型胰腺功能不全的功效和安全性。
3. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis [J] . Michael W. Konstan, Theodore G. Liou, Steven D. Strausbaugh, Gastroenterology research and practice . 2010,第Gastroenterology期

机译：新型胰酶（Ultrase MT20）治疗囊性纤维化外分泌性胰腺功能不全的吸收不良的疗效和安全性
4. Enhancing Self-Efficacy for Self-Management in People with Cystic Fibrosis [C] . Elizabeth CUMMINGS, Jenny HAUSER, Helen CAMERON-TUCKER Medical Informatics in Europe Conference. . 2011

机译：增强囊性纤维化人民自我管理的自我效能
5. Assessing pancreatic enzyme efficacy in patients with cystic fibrosis: Evaluation of a combination approach using unprotected pancreatic enzymes and pH-sensitive enteric-coated microspheres. [D] . Kalnins, Daina Brigita. 2003

机译：评估囊性纤维化患者的胰酶功效：使用未保护的胰酶和pH敏感的肠溶微球的组合方法评估。
6. Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis [O] . Michael W. Konstan, Theodore G. Liou, Steven D. Strausbaugh, 2010

机译：新型胰酶（Ultrase MT20）治疗囊性纤维化外分泌性胰腺功能不全的吸收不良的疗效和安全性
7. Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis [O] . Trapnell Bruce C., Strausbaugh Steven D., Woo Marlyn S., 2011

机译：PANCREAZE®治疗因囊性纤维化引起的外分泌型胰腺功能不全的功效和安全性
8. A Study to Determine the Efficacy and Reactivity of Influenza Vaccine in Patients with Cystic Fibrosis and in Other High Risk Groups [R] . Gross, P. A. 1980

机译：确定囊性纤维化患者和其他高危人群流感疫苗的有效性和反应性的研究

Corrigendum to “Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis” J Cyst Fibros, 10(2011)350-356

著录项

引文网络

相似文献

相关主题

期刊订阅